Omega Healthcare Investors Inc.
OHI
$46.98
+0.30%
Omega Healthcare Investors Inc. is a self-managed healthcare real estate investment trust that owns and finances skilled nursing facilities, assisted living facilities, independent living communities, rehabilitation and acute care properties, and continuing care retirement communities across the United States, the United Kingdom, and Canada, operating as a capital partner to third-party healthcare operators. With a roughly $13-14 billion market capitalization and a deliberately lean 69-employee corporate structure, Omega is one of the largest dedicated owners of skilled nursing real estate in the public markets and functions as a pure-play income vehicle rather than a diversified REIT, distinguishing it from hospital-heavy peers such as Medical Properties Trust. The current investor debate centers on the durability of operator rent coverage and tenant credit quality in a post-pandemic skilled nursing environment, set against a portfolio that has delivered double-digit revenue growth (Q1 2026 revenue up 16.7% year over year) and a dividend yield near 5.9% that anchors the income thesis. Sentiment has been complicated by a mixed sell-side stance — Barclays downgraded to Underweight in July 2026 and BofA moved to Underperform in April 2026 — even as the stock has outperformed over twelve months, leaving investors to weigh the yield and growth against valuation and rate sensitivity.…
OHI
Omega Healthcare Investors Inc.
$46.98
Related headlines
Investment Opinion: Should I buy OHI Today?
We rate OHI a Hold. The stock offers a compelling 5.9% dividend yield and has demonstrated strong revenue growth of 16.7% YoY, but the valuation appears fair to slightly rich at 2.53x book value and 21.95x trailing PE, while operator credit risks and recent analyst downgrades temper enthusiasm. The analyst consensus is Buy with an average target of $51.37, implying 11.1% upside, but we see limited margin of safety.
Supporting evidence includes: (1) revenue growth of 16.7% YoY in Q1 2026, well above the healthcare REIT sector average of ~5-7%; (2) a dividend yield of 5.94%, among the highest in the sector, backed by $907M in trailing free cash flow; (3) a low beta of 0.526, providing defensive characteristics; and (4) a PEG ratio of 0.77, suggesting growth is reasonably priced relative to earnings. However, the P/B of 2.53x is a premium to book, and the payout ratio of 132% on EPS raises concerns about dividend coverage, though FFO-based payout is more comfortable.
Key risks that could invalidate the thesis include a major tenant default, a dividend cut, or a sharp rise in interest rates. We would upgrade to Buy if the stock pulls back to the $42-44 range (offering a yield above 6.5%) or if operator rent coverage improves significantly. We would downgrade to Sell if the dividend is cut or if revenue growth decelerates below 5%. Overall, the stock appears fairly valued relative to its history and peers, with the dividend providing a floor but limited upside.
Sign up to view all
OHI 12-Month Price Forecast
We have a neutral stance on OHI with medium confidence. The company's strong revenue growth and high dividend yield are attractive, but the premium valuation and operator credit risks limit upside. The stock's recent underperformance (-10.6% over 3 months) and mixed analyst sentiment suggest caution. We would upgrade to bullish if revenue growth accelerates above 15% and dividend coverage improves, or downgrade to bearish if a tenant default occurs or the dividend is cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Omega Healthcare Investors Inc.'s 12-month outlook, with a consensus price target around $51.37 and implied upside of +9.3% versus the current price.
Average Target
$51.37
0 analysts
Implied Upside
+9.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$45 - $61
Analyst target range
Bulls vs Bears: OHI Investment Factors
The bull case rests on strong revenue growth (16.7% YoY), a high dividend yield (5.9%), and a discounted valuation relative to peers, supported by a low beta and analyst Buy consensus. However, the bear case highlights premium P/B (2.53x), recent relative underperformance (-13.5% vs. S&P over 3 months), and operator credit risks that could pressure dividends. The most important tension is whether OHI can sustain its growth and dividend coverage amid tenant challenges and a higher-for-longer rate environment. Currently, the bear evidence appears slightly stronger due to momentum breakdown and valuation concerns, but the bull case has merit if growth continues.
Bullish
- Double-digit revenue growth: Q1 2026 revenue rose 16.7% YoY to $322.96M from $276.79M in Q1 2025, driven by portfolio expansion and rent escalators. This is well above the typical low-single-digit growth for healthcare REITs and supports the income-growth thesis.
- High dividend yield with strong coverage: The stock yields 5.94%, backed by trailing free cash flow of $907M and a payout ratio of 132% on EPS but only ~70% on FFO (implied). The quarterly dividend of $0.67 is well covered by recurring cash flow, making the yield sustainable.
- Attractive valuation vs. peers: At 21.95x trailing PE and 14.84x EV/EBITDA, OHI trades at a discount to healthcare REIT peers (e.g., WELL at ~25x PE, VTR at ~20x). The PEG ratio of 0.77 suggests growth is not fully priced in.
- Low beta and defensive characteristics: Beta of 0.526 indicates low correlation to the broader market, providing portfolio diversification. The stock has returned 13.6% over the past year, slightly outpacing the S&P 500's 13.1%.
Bearish
- Premium valuation to book: P/B of 2.53x is elevated for a REIT, where book value approximates net asset value. This suggests the market is pricing in growth that may not materialize, leaving downside if sentiment reverses.
- Recent price weakness and relative underperformance: The stock is down 10.6% over three months and has underperformed the S&P 500 by 13.5 percentage points in that period. This momentum breakdown could signal deteriorating fundamentals or sector rotation.
- High leverage and interest rate sensitivity: Debt-to-equity of 0.82 and interest expense of $49.8M in Q1 2026 (15.4% of revenue) expose OHI to refinancing risk. With rates staying higher for longer, cost of capital remains a headwind.
- Operator credit risk in skilled nursing: OHI's tenants face labor shortages and reimbursement pressures. Any major tenant default or rent coverage deterioration could trigger dividend cuts or asset impairments, as seen with prior operator restructurings.
OHI Technical Analysis
Beta
0.53
0.53x market volatility
Max Drawdown
-15.4%
Largest decline past year
52-Week Range
$40-$52
Price range past year
Annual Return
+17.8%
Cumulative gain past year
| Period | OHI Return | S&P 500 |
|---|---|---|
| 1m | +1.4% | -0.9% |
| 3m | -7.2% | +1.2% |
| 6m | +0.0% | +4.9% |
| 1y | +17.8% | +11.2% |
| ytd | +5.5% | +10.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
OHI Fundamental Analysis
Quarterly Revenue
$322955000.0B
2026-03
Revenue YoY Growth
+16.7%
YoY Comparison
Gross Margin
97.2%
Latest Quarter
Free Cash Flow
$907053000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is OHI Overvalued?
PE
22.0x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 10x~46x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are moderate but notable. OHI carries debt-to-equity of 0.82 and interest expense of $49.8M in Q1 2026, representing 15.4% of revenue, which could strain cash flow if rates rise. The payout ratio of 132% on EPS raises questions about dividend sustainability, though free cash flow of $907M provides coverage. Revenue is concentrated in skilled nursing facilities, making the company vulnerable to operator defaults or regulatory changes in Medicare/Medicaid reimbursement. Additionally, the company's small 69-employee structure means it relies heavily on third-party operators, and any tenant bankruptcy could lead to rent interruptions and asset impairments.
Market and competitive risks include valuation compression and sector rotation. OHI trades at 2.53x book value, a premium for a REIT, and 14.84x EV/EBITDA, which is above some peers. With a beta of 0.526, the stock is less sensitive to market swings, but rising interest rates could still pressure REIT valuations as dividend yields become less attractive relative to bonds. Recent analyst downgrades (Barclays to Underweight in July 2026, BofA to Underperform in April 2026) reflect concerns about growth sustainability and operator credit quality. Competition from other healthcare REITs like Welltower and Ventas, which have stronger balance sheets, could limit OHI's ability to acquire properties at attractive cap rates.
Worst-case scenario: A major tenant default or a significant decline in rent coverage could trigger a dividend cut, leading to a sharp sell-off. The 52-week low is $39.26, representing a 15.1% decline from the current price of $46.23. If operator troubles escalate and the dividend is cut, the stock could fall to the analyst low target of $45 (only 2.7% downside) or below, potentially testing the 52-week low. A more severe scenario, such as multiple tenant failures, could push the stock down 20-30% to the low $30s, though this is not our base case. The maximum drawdown over the past period was -15.41%, indicating moderate volatility.
FAQ
The key risks include: (1) operator credit risk, as OHI's tenants face labor shortages and reimbursement pressures, which could lead to rent defaults; (2) dividend sustainability, given the 132% payout ratio on EPS, though free cash flow coverage is better; (3) interest rate risk, as rising rates increase borrowing costs and reduce REIT valuations; and (4) regulatory risk, with potential changes to Medicare/Medicaid reimbursement affecting operator profitability. These risks are ranked from highest to lowest severity, with operator credit being the most immediate concern.
Our 12-month forecast has three scenarios: Bull (25% probability) with a target range of $55-61, Base (50%) with $48-53, and Bear (25%) with $39-45. The base case assumes revenue growth of 8-10%, stable operator performance, and a maintained dividend, leading to a modest total return. The most likely scenario is the base case, with the stock reaching the analyst average target of $51.37, implying 11.1% upside. Key assumptions include no major tenant defaults and stable interest rates.
OHI appears fairly valued to slightly overvalued. Its trailing PE of 21.95x is in line with the healthcare REIT sector, but its P/B of 2.53x is a premium to book value, which is high for a REIT. The PEG ratio of 0.77 suggests growth is reasonably priced, but the dividend payout ratio of 132% on EPS raises questions about sustainability. Compared to peers like Welltower (P/B ~2.0x) and Ventas (P/B ~1.8x), OHI trades at a premium, implying the market expects continued growth. However, the 5.9% yield provides support, and the stock is not egregiously overvalued.
OHI may be a good buy for income-focused investors seeking a high dividend yield of 5.94%, which is well above the S&P 500 average. The stock has strong revenue growth of 16.7% YoY and trades at a reasonable 21.95x trailing PE, with analyst consensus Buy and an average target of $51.37 (11.1% upside). However, risks include a premium P/B of 2.53x, recent relative underperformance, and operator credit concerns. It is best suited for those with a long-term horizon who can tolerate some volatility in exchange for steady income.
OHI is more suitable for long-term investment, particularly for income-focused investors. Its low beta of 0.526 and high dividend yield of 5.94% make it a defensive holding, but the operator credit risks and interest rate sensitivity require a longer horizon to ride out volatility. Short-term trading is less advisable due to the stock's recent 10.6% three-month decline and mixed analyst sentiment. We recommend a minimum holding period of 2-3 years to benefit from dividend compounding and potential capital appreciation.